BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26056584)

  • 1. MicroRNAs: short non-coding players in cancer chemoresistance.
    Donzelli S; Mori F; Biagioni F; Bellissimo T; Pulito C; Muti P; Strano S; Blandino G
    Mol Cell Ther; 2014; 2():16. PubMed ID: 26056584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in chemoresistance.
    Magee P; Shi L; Garofalo M
    Ann Transl Med; 2015 Dec; 3(21):332. PubMed ID: 26734642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance.
    Naidu S; Garofalo M
    Front Med (Lausanne); 2015; 2():77. PubMed ID: 26583081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance.
    Ayers D; Vandesompele J
    Genes (Basel); 2017 Mar; 8(3):. PubMed ID: 28273813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of microRNAs on the resistance of breast cancer subtypes to chemotherapy.
    Ebrahimi A; Bakhshaei Shahrebabaki P; Fouladi H; Mansoori Derakhshan S
    Pathol Res Pract; 2023 Sep; 249():154702. PubMed ID: 37562283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the role of microRNA in lung cancer resistance to treatment and targeted therapy.
    Gong Z; Yang J; Li J; Yang L; Le Y; Wang S; Lin HK
    Curr Cancer Drug Targets; 2014; 14(3):241-58. PubMed ID: 24605945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
    Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer.
    Ranade AR; Cherba D; Sridhar S; Richardson P; Webb C; Paripati A; Bowles B; Weiss GJ
    J Thorac Oncol; 2010 Aug; 5(8):1273-8. PubMed ID: 20548249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
    Wang J; Yang M; Li Y; Han B
    Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.
    Jayaraj R; Polpaya K; Kunale M; Kodiveri Muthukaliannan G; Shetty S; Baxi S; Mani RR; Paranjothy C; Purushothaman V; Kayarohanam S; Janakiraman AK; Balaraman AK
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553594
    [No Abstract]   [Full Text] [Related]  

  • 12. The miRNAs involved in prostate cancer chemotherapy response as chemoresistance and chemosensitivity predictors.
    Konoshenko M; Laktionov P
    Andrology; 2022 Jan; 10(1):51-71. PubMed ID: 34333834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators.
    Mirzaei S; Zarrabi A; Asnaf SE; Hashemi F; Zabolian A; Hushmandi K; Raei M; Goharrizi MASB; Makvandi P; Samarghandian S; Najafi M; Ashrafizadeh M; Aref AR; Hamblin MR
    Life Sci; 2021 Mar; 268():119005. PubMed ID: 33421526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer: miRNAs monitoring chemoresistance and systemic therapy.
    Singh S; Saini H; Sharma A; Gupta S; Huddar VG; Tripathi R
    Front Oncol; 2023; 13():1155254. PubMed ID: 37397377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.
    Cui SY; Wang R; Chen LB
    J Cell Mol Med; 2013 Oct; 17(10):1207-17. PubMed ID: 24106980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and mechanisms of action of microRNAs in cancer drug resistance.
    Si W; Shen J; Zheng H; Fan W
    Clin Epigenetics; 2019 Feb; 11(1):25. PubMed ID: 30744689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.
    Liu X; Fu Q; Du Y; Yang Y; Cho WC
    Curr Cancer Drug Targets; 2016; 16(9):738-754. PubMed ID: 26577538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer.
    Funamizu N; Honjo M; Tamura K; Sakamoto K; Ogawa K; Takada Y
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.